Trials / Completed
CompletedNCT01917643
Comparative Effectiveness of Symbicort vs. Spiriva Among COPD Patients
A U.S. Retrospective Database Analysis Evaluating the Comparative Effectiveness of Budesonide/Formoterol (BFC) and Tiotropium Bromide Among COPD Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,396 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
This study is intended to evaluate treatment effectiveness with budesonide/formoterol (BFC) and tiotropium tromide in patients new to ICS/LABA combination and LAMA therapies.
Detailed description
Using US claims data from the HealthCore Integrated Research Environment, COPD patients ≥40 years old initiating BFC or tiotropium between 3/1/2009-2/28/2012 and considered at risk for a future exacerbation were identified and followed for 12 months.
Conditions
Timeline
- Start date
- 2013-08-01
- Primary completion
- 2013-11-01
- Completion
- 2013-11-01
- First posted
- 2013-08-07
- Last updated
- 2016-02-03
Source: ClinicalTrials.gov record NCT01917643. Inclusion in this directory is not an endorsement.